Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Hepatocellular × Standard of Care × Clear all

Sponsor

Conditions

Breast Neoplasms 11 Pancreatic Neoplasms 6 Prostatic Neoplasms 5 Ovarian Neoplasms 5 Leukemia, Myeloid, Acute 5 Head and Neck Neoplasms 5 Urinary Bladder Neoplasms 4 Neoplasms 4 Multiple Myeloma 4 Lung Neoplasms 4 Leukemia 4 Recurrence 3 Neoplasms, Plasma Cell 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Rectal Neoplasms 2 Radiodermatitis 2 Neoplasms by Site 2 Myelodysplastic Syndromes 2 Melanoma 2 Hematologic Neoplasms 2 Gastrointestinal Neoplasms 2 Carcinoma, Transitional Cell 2 Urologic Neoplasms 1 Urologic Diseases 1 Urogenital Neoplasms 1 Urinary Bladder Diseases 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1

Interventions

Sorafenib 49 pembrolizumab 20 Nivolumab 18 Bevacizumab 16 Radiosurgery 15 Doxorubicin 12 lenvatinib 8 Erlotinib Hydrochloride 7 atezolizumab 6 Ramucirumab 6 Magnetic Resonance Spectroscopy 6 Cisplatin 6 tremelimumab 5 durvalumab 5 cabozantinib 5 Radiofrequency Ablation 5 tislelizumab 4 Sunitinib 4 Ipilimumab 4 regorafenib 3 nintedanib 3 carotuximab 3 bavituximab 3 Ribavirin 3 Radiotherapy 3 Oxaliplatin 3 Mitomycin 3 Leucovorin 3 Fluorouracil 3 Everolimus 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡